A multicenter, multicohort, phase 2 study of trastuzumab deruxtecan (DS-8201a) in subjects with HER2-expressing metastatic colorectal cancer - Trial in progress

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 29; p. v83
Main Authors Yoshino, T., Siena, S., Dalal, R., Okuda, Y., Yamamoto, E., Grothey, A.
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.06.2018
Online AccessGet full text

Cover

Author Siena, S.
Grothey, A.
Yamamoto, E.
Okuda, Y.
Yoshino, T.
Dalal, R.
Author_xml – sequence: 1
  givenname: T.
  surname: Yoshino
  fullname: Yoshino, T.
  organization: National Cancer Center Hospital East, Kashiwa, Japan
– sequence: 2
  givenname: S.
  surname: Siena
  fullname: Siena, S.
  organization: Niguarda Cancer Center, Università degli Studi di Milano, Milan, Italy
– sequence: 3
  givenname: R.
  surname: Dalal
  fullname: Dalal, R.
  organization: Daiichi Sankyo, Inc., Basking Ridge
– sequence: 4
  givenname: Y.
  surname: Okuda
  fullname: Okuda, Y.
  organization: Daiichi Sankyo Co., Ltd, Tokyo, Japan
– sequence: 5
  givenname: E.
  surname: Yamamoto
  fullname: Yamamoto, E.
  organization: Daiichi Sankyo Co., Ltd, Chuo-ku, Japan
– sequence: 6
  givenname: A.
  surname: Grothey
  fullname: Grothey, A.
  organization: Mayo Clinic, Rochester
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32177282$$D View this record in MEDLINE/PubMed
BookMark eNp9kUtP3DAUha2KqgyPH9BNdZcgEbCdOJmIFeJZCQmJxzry44YxSuLIdlqmv6Y_FY8CXXTByr7W-Y51z9khW4MbkJDvjB4zWucnckgP-qQ3aybYMa-LL2TBRFlnS1qwLbKgNc-zSuTFNtkJ4YVSWta8_ka2c86qii_5gvw9g37qotU4RPRH74NbOR-PYFzJgMAhxMmswbUQvUz3P1MvFRj002tELQc4uHjIlpwyeQh2gDCpF9QxwG8bV3Bzec8zfB09hmCHZ-gxJg-ZPgHtOueTUnaQXDR6yODR2zQml9G75w2zR762sgu4_37ukqery8fzm-z27vrn-dltpnm1LDJdykKomtJclEJQI4xBppWqmDa8pFQLJk0rCqVSBBVrFRbK5GjKlrWsoDLfJT9m33FSPZpm9LaXft18RJUEbBZo70Lw2P6TMNps6mjmOpq5jibVkZjqP0bbze5uSEna7lPydCYx7fzLom-CtphCMnYTWWOc_YR-A409qhw
CitedBy_id crossref_primary_10_3390_cancers12113481
ContentType Journal Article
Copyright 2018 THE AUTHORS
Copyright_xml – notice: 2018 THE AUTHORS
DBID 6I.
AAFTH
AAYXX
CITATION
NPM
DOI 10.1093/annonc/mdy151.294
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
PubMed
DatabaseTitle CrossRef
PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1569-8041
EndPage v83
ExternalDocumentID 32177282
10_1093_annonc_mdy151_294
S0923753419340311
Genre Journal Article
GroupedDBID ---
-E4
.2P
.86
.I3
.XZ
.ZR
08P
0R~
0U7
1TH
23M
2WC
4.4
482
48X
53G
5GY
5VS
5WA
6.Y
6I.
6J9
70D
AABJS
AABMN
AAEDW
AAESY
AAFTH
AAIAV
AAIYJ
AAJKP
AAJQQ
AAKAS
AAKUH
AAMVS
AAOGV
AAPNW
AAUQX
AAXUO
ABEUO
ABIXL
ABJNI
ABKDP
ABLJU
ABNKS
ABOCM
ABQLI
ABQTQ
ABSAR
ABSMQ
ABVKL
ABZBJ
ACGFO
ACGFS
ACIMA
ACMRT
ACPQN
ACPRK
ACUFI
ACUTO
ADBBV
ADEIU
ADEYI
ADHKW
ADHZD
ADJQC
ADOCK
ADORX
ADQLU
ADRIX
ADRTK
ADYVW
ADZCM
ADZXQ
AEGPL
AEGXH
AEJOX
AEKPW
AEKSI
AEMDU
AENEX
AENZO
AEPUE
AEWNT
AFIYH
AFOFC
AFXEN
AGINJ
AGKEF
AGKRT
AGSYK
AHMBA
AHXPO
AIAGR
AIJHB
AIKOY
AITUG
ALMA_UNASSIGNED_HOLDINGS
ALUQC
AMRAJ
APIBT
APWMN
AQKUS
ASMCH
ASPBG
ATTQO
AVWKF
AWCFO
AXUDD
AZFZN
AZQFJ
BAWUL
BAYMD
BEYMZ
BGNMA
BGYMP
BHONS
BTRTY
BVRKM
BZKNY
C1A
CAG
CASEJ
CDBKE
CKLRP
COF
CS3
CZ4
DAKXR
DIK
DILTD
DL5
DPORF
DPPUQ
D~K
E3Z
EBS
EE~
EJD
EX3
F9B
FDB
FEDTE
GJXCC
GX1
H5~
HAR
HVGLF
HW0
HZ~
I09
IH2
IHE
IOX
J21
KAQDR
KC5
KDC
KOM
KOP
KQ8
KSI
KSN
LAK
M-Z
M41
M49
M4Y
MBLQV
MHKGH
N9A
NCXOZ
NGC
NOYVH
NTWIH
NU-
NU0
NVLIB
O9-
OAWHX
ODMLO
OJQWA
OK1
OVD
P2P
P6G
PAFKI
PB-
PEELM
PQQKQ
Q1.
Q5Y
QBD
R44
RD5
RNI
ROL
ROX
ROZ
RPX
RW1
RXO
RZC
RZE
RZF
RZO
SDH
TCURE
TEORI
TJX
TMA
TR2
U2A
W8F
WOQ
WOW
X7H
YAYTL
YFH
YKOAZ
ZKX
ZXP
~91
AAGQS
AALRI
AAYWO
AAYXX
ABNGD
ACUKT
ACVFH
ADCNI
ADVLN
AEHUL
AEUPX
AFETI
AFJKZ
AFPUW
AFSHK
AGCQF
AGQPQ
AIGII
AKBMS
AKRWK
AKYEP
APXCP
CITATION
H13
NPM
ID FETCH-LOGICAL-c2784-c6a45b900356550d5dde1cbb71cd2600c51adf54bb69271fbe4bd3ed6f1f140a3
ISSN 0923-7534
IngestDate Wed Feb 19 02:30:41 EST 2025
Tue Jul 01 03:51:20 EDT 2025
Thu Apr 24 22:56:34 EDT 2025
Fri Feb 23 02:47:26 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Language English
License http://www.elsevier.com/open-access/userlicense/1.0
https://www.elsevier.com/tdm/userlicense/1.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c2784-c6a45b900356550d5dde1cbb71cd2600c51adf54bb69271fbe4bd3ed6f1f140a3
OpenAccessLink https://dx.doi.org/10.1093/annonc/mdy151.294
PMID 32177282
ParticipantIDs pubmed_primary_32177282
crossref_primary_10_1093_annonc_mdy151_294
crossref_citationtrail_10_1093_annonc_mdy151_294
elsevier_sciencedirect_doi_10_1093_annonc_mdy151_294
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate June 2018
2018-06-00
2018-Jun
PublicationDateYYYYMMDD 2018-06-01
PublicationDate_xml – month: 06
  year: 2018
  text: June 2018
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Annals of oncology
PublicationTitleAlternate Ann Oncol
PublicationYear 2018
Publisher Elsevier Ltd
Publisher_xml – name: Elsevier Ltd
SSID ssj0006929
Score 2.2589011
SourceID pubmed
crossref
elsevier
SourceType Index Database
Enrichment Source
Publisher
StartPage v83
Title A multicenter, multicohort, phase 2 study of trastuzumab deruxtecan (DS-8201a) in subjects with HER2-expressing metastatic colorectal cancer - Trial in progress
URI https://dx.doi.org/10.1093/annonc/mdy151.294
https://www.ncbi.nlm.nih.gov/pubmed/32177282
Volume 29
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELeqISFeEN-ML_mBB6BLlzhOWj9WdKiABtLaSdtTZDsOK2zpVBoE-2v4D_gXubOdDxgasJfIsRIn9e_Xu_PlfEfIU6NCYUTCAYG0CLhgo0CGWgew8hAFWOSc2Tzdu-_S6T5_c5Ac9Ho_OlFL1VoN9Nkf95VcBlXoA1xxl-x_INsMCh3QBnzhCAjD8Z8wHrt4QAywdDPvTpdHvjz86RHoqD5zOWRtNMBKQvusOpGqn5tVhSlcJcI_mswC1NISvQSLsv-5Uh9tnIf100539lhgvrqY2fIDlp2WuBNpofuY9BqFJqYZQQJh9bu5qwTig7_qEI9zGZuXpf7Fp3-4RHeYdd3OB43nB0SPtW9nTddEHtsqBf29puv9pyq3Vx0Oum6MaNSGWznfWr2_pg1msk5KFgewoHIuB-NFdCoCzJrUleHea-KE8BdXGsfrc392TlW4NFqyLOHXQuMk_wbGz4AJ3mrGJl5xhi-C7wHmLgcxCMvtKwzWJVgyY_L6baP6U8Fcckf_2vVndBFvuwdtt4_5iyHUsXLmN8h1vzyhY8e1m6Rnylvk6q4PwLhNvo9ph3JbtEO4LWrpRhm1dKPLgnboRlu60Wc12Z7TRUlrqlGkGv2NarSlGm2pRh3VaEAt1XCUmmp3yP6rnfnLaeCLfAQav3kHOpU8UehPh6VFEuYJ6NtIKzWMdI7FE3QSybxIuFIwucOoUIarPDZ5WkQgS0IZ3yUbMLPmPqFgiqvIiGikmea5kiJPZcqGMhIc9A6XmySsZzzTPgM-FmI5zlwkRpw5kDIHUgYgbZIXzS2nLv3LRRfzGsbM26_OLs2Acxfdds9B3jwhZhGQa8QeXG7Ah-Ra-w97RDbWq8o8BtN5rZ5Yuv4E0YLIIA
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+multicenter%2C+multicohort%2C+phase+2+study+of+trastuzumab+deruxtecan+%28DS-8201a%29+in+subjects+with+HER2-expressing+metastatic+colorectal+cancer+-+Trial+in+progress&rft.jtitle=Annals+of+oncology&rft.au=Yoshino%2C+T.&rft.au=Siena%2C+S.&rft.au=Dalal%2C+R.&rft.au=Okuda%2C+Y.&rft.date=2018-06-01&rft.pub=Elsevier+Ltd&rft.issn=0923-7534&rft.eissn=1569-8041&rft.volume=29&rft.spage=v83&rft.epage=v83&rft_id=info:doi/10.1093%2Fannonc%2Fmdy151.294&rft.externalDocID=S0923753419340311
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0923-7534&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0923-7534&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0923-7534&client=summon